Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Nov 7;283(6301):1207–1209. doi: 10.1136/bmj.283.6301.1207

Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.

J Bayliss
PMCID: PMC1507428  PMID: 6797511

Abstract

A young woman had severe brittle diabetes mellitus that was critically unmanageable with all conventional insulin treatment. Continuous subcutaneous and intramuscular infusions of insulin also failed to control her metabolic instability. Use of a continuous intravenous infusion, however, whereby a portable, variable-rate, battery-operated syringe pump delivered insulin through a subcutaneously tunnelled central venous catheter, resulted in good control. When she was receiving hourly intramuscular insulin injections (a mean of 778 IU daily) mean blood glucose concentrations had been 22.1 +/- 1.4 mmol/l (398 +/- 25 mg/100 microliters). After she had received the intravenous infusion for one month as an outpatient mean blood glucose concentration was 8.2 +/- 0.46 mmol/l (148 +/- 8 mg/100 microliters) and only 80 IU insulin daily was required. Follow-up after over five months of use showed that few complications had occurred. The system is simple to use and safe, and the diabetes had been stabilised such that she could enjoy a near-normal life style.

Full text

PDF
1207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey M. J. Reduction of catheter-associated sepsis in parenteral nutrition using low-dose intravenous heparin. Br Med J. 1979 Jun 23;1(6179):1671–1673. doi: 10.1136/bmj.1.6179.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berger M., Halban P. A., Girardier L., Seydoux J., Offord R. E., Renold A. E. Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site. Diabetologia. 1979 Aug;17(2):97–99. doi: 10.1007/BF01222209. [DOI] [PubMed] [Google Scholar]
  3. Dandona P., Foster M., Healey F., Greenbury E., Beckett A. G. Low-dose insulin infusions in diabetic patients with high insulin requirements. Lancet. 1978 Aug 5;2(8084):283–285. doi: 10.1016/s0140-6736(78)91688-4. [DOI] [PubMed] [Google Scholar]
  4. Freidenberg G. R., White N., Cataland S., O'Dorisio T. M., Sotos J. F., Santiago J. V. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. N Engl J Med. 1981 Aug 13;305(7):363–368. doi: 10.1056/NEJM198108133050702. [DOI] [PubMed] [Google Scholar]
  5. Heimbach D. M., Ivey T. D. Technique for placement of a permanent home hyperalimentation catheter. Surg Gynecol Obstet. 1976 Oct;143(4):634–636. [PubMed] [Google Scholar]
  6. Kurtz A. B., Matthews J. A., Mustaffa B. E., Daggett P. R., Nabarro J. D. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia. 1980;18(2):147–150. doi: 10.1007/BF00290492. [DOI] [PubMed] [Google Scholar]
  7. Nakagawa S., Nakayama H., Sasaki T., Yoshino K., Yu Y. Y. A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes. 1973 Aug;22(8):590–600. doi: 10.2337/diab.22.8.590. [DOI] [PubMed] [Google Scholar]
  8. Paulsen E. P., Courtney J. W., 3rd, Duckworth W. C. Insulin resistance caused by massive degradation of subcutaneous insulin. Diabetes. 1979 Jul;28(7):640–645. doi: 10.2337/diab.28.7.640. [DOI] [PubMed] [Google Scholar]
  9. Pickup J. C., Home P. D., Bilous R. W., Keen H., Alberti K. G. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J (Clin Res Ed) 1981 Jan 31;282(6261):347–350. doi: 10.1136/bmj.282.6261.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pickup J. C., Keen H., Parsons J. A., Alberti K. G. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J. 1978 Jan 28;1(6107):204–207. doi: 10.1136/bmj.1.6107.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pickup J. C., Keen H., Parsons J. A., Alberti K. G., Rowe A. S. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics. Lancet. 1979 Jun 16;1(8129):1255–1257. doi: 10.1016/s0140-6736(79)92225-6. [DOI] [PubMed] [Google Scholar]
  12. Pickup J. C., White M. C., Keen H., Parsons J. A., Alberti K. G. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet. 1979 Oct 27;2(8148):870–873. doi: 10.1016/s0140-6736(79)92686-2. [DOI] [PubMed] [Google Scholar]
  13. Riella M. C., Scribner B. H. Five years' experience with a right atrial catheter for prolonged parenteral nutrition at home. Surg Gynecol Obstet. 1976 Aug;143(2):205–208. [PubMed] [Google Scholar]
  14. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979 Mar 15;300(11):573–578. doi: 10.1056/NEJM197903153001101. [DOI] [PubMed] [Google Scholar]
  15. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump. Lancet. 1979 Jun 16;1(8129):1258–1261. doi: 10.1016/s0140-6736(79)92226-8. [DOI] [PubMed] [Google Scholar]
  16. Watkins P. J. Insulin infusion systems, diabetic control, and microvascular complications. Br Med J. 1980 Feb 9;280(6211):350–352. doi: 10.1136/bmj.280.6211.350. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES